Marine biomedicine : from beach to bedside /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Boca Raton :
CRC Press, Taylor and Francis Group,
[2016]
|
| Subjects: |
Table of Contents:
- Accessing chemical diversity through metagenomics / Leah C. Blasiak and Russell T. Hill
- Chemical characterization of marine organisms using a metabolomics approach / Kashif Ali, Robert Verpoorte, Erica G. Wilson and Young Hae Choi
- Biosynthetic approaches to marine drug discovery and development / Eric W. Schmidt
- Dereplication of natural products using databases / Hartmut Laatsch
- Logistic considerations to deliver natural product libraries for high throughput screening / Ngoc B. Pham, Stephen Toms, David Camp and Ronald J. Quinn
- Screening marine microbial libraries / Jacqueline L. von Salm, Christopher G. Witowski, Danielle H. Demers, Ryan M. Young, Laurent Calcul and Bill J. Baker
- Screening strategies for drug discovery and target identification / Fatma H. Al-Awadhi, Lilibeth A. Salvador and Hendrik Luesch
- Anti-infective agents from marine sources / Cedric Pearce
- Screening for antiparasitic marine natural products / Ryan M. Young and Eva-Rachele Pesce
- Central nervous system modulators from the oceans / Kh Tanvir Ahmed, Neil Lax and Kevin Tidgewell
- Marine organisms in cancer chemoprevention / Eun-Jung Park, Anam Shaikh, Brian T. Murphy and John M. Pezzuto
- Off the beaten path : natural products from extreme environments / Samantha M. Gromek, Ashley M. West and Marcy J. Balunas
- Bioprospecting fungi and the labyrinthulomycetes at the ocean-land interface / Ka-Lai Pang, Clement K.M. Tsui, E.B. Gareth Jones and Lilian L.P. Vrijmoed
- Medicinal chemistry and lead optimization of marine natural products / Jim W. Leahy
- The travails of clinical trials with marine-sourced compounds / David J. Newman and Gordon M. Cragg
- Conopeptides, marine natural products from venoms: biomedical applications and future research applications / Baldomero M. Olivera, Helena Safavi-Hemami, Martin P. Horvath, and Russell W. Teichert
- The development and commercialization of a fully synthetic marine natural product analogue, halaven® (eribulin mesylate) / Charles E. Chase, Hyeong-wook Choi, Atsushi Endo, Francis G. Fang and John D. Orr
- Marine natural products in pharma : how industry missed the boat / Guy Carter and Valerie Bernan
- In vitro model for defining neurotoxicity of anticancer agents / Balanehru Subramanian, Halina Pietraszkiewicz, Joseph E. Media and Frederick A. Valeriote
- Comments on the past and future of marine natural products drug discovery / Bill Fenica.